Literature DB >> 28726490

Psychotropic drug prescription for nursing home residents with dementia: prevalence and associations with non-resident-related factors.

Claudia H W Smeets1,2, Debby L Gerritsen1,2, Sytse U Zuidema3, Steven Teerenstra4, Klaas van der Spek1,2, Martin Smalbrugge5, Raymond T C M Koopmans1,2,6.   

Abstract

OBJECTIVES: To determine psychotropic drug prescription rates in nursing home residents with dementia and to identify associations with the so far understudied psychosocial non-resident-related factors.
METHOD: A cross-sectional, observational, exploratory design as part of PROPER I (PRescription Optimization of Psychotropic drugs in Elderly nuRsing home patients with dementia). Participants were 559 nursing home residents with dementia, 25 physicians, and 112 nurses in the Netherlands. Psychotropic drug prescription, non-resident-related and known resident-related variables were measured to operationalize the themes of our previous qualitative analysis.
RESULTS: Fifty-six percent of residents were prescribed any psychotropic drug, 25% antipsychotics, 29% antidepressants, 15% anxiolytics, and 13% hypnotics, with large differences between the units. Multivariate multilevel regression analyses revealed that antipsychotic prescription was less likely with higher physicians' availability (odds ratio 0.96, 95% confidence interval 0.93-1.00) and that antidepressant prescription was more likely with higher satisfaction of nurses on resident contact (odds ratio 1.50, 95% confidence interval 1.00-2.25). Resident-related factors explained 6%-15% of the variance, resident- and non-resident-related factors together 8%-17%.
CONCLUSION: Prescription rates for antipsychotics are similar compared to other countries, and relatively low for antidepressants, anxiolytics, and hypnotics. Our findings indicate that improvement of prescribing could provisionally best be targeted at resident-related factors.

Entities:  

Keywords:  Dementia; nursing home; psychotropics

Mesh:

Substances:

Year:  2017        PMID: 28726490     DOI: 10.1080/13607863.2017.1348469

Source DB:  PubMed          Journal:  Aging Ment Health        ISSN: 1360-7863            Impact factor:   3.658


  7 in total

1.  Polypharmacy in Assisted Living and Impact on Clinical Outcomes.

Authors:  Barbara Resnick; Elizabeth Galik; Marie Boltz; Sarah Holmes; Steven Fix; Erin Vigne; Shijun Zhu; Regina Lewis
Journal:  Consult Pharm       Date:  2018-06-01

Review 2.  Music-based interventions in the acute setting for patients with dementia: a systematic review.

Authors:  Lídia Sousa; Becky Dowson; Orii McDermott; Justine Schneider; Lia Fernandes
Journal:  Eur Geriatr Med       Date:  2020-08-16       Impact factor: 1.710

3.  Trends in Antipsychotic and Mood Stabilizer Prescribing in Long-Term Care in the U.S.: 2011-2014.

Authors:  Lauren B Gerlach; Helen C Kales; Hyungjin Myra Kim; Julie P W Bynum; Claire Chiang; Julie Strominger; Donovan T Maust
Journal:  J Am Med Dir Assoc       Date:  2020-07-18       Impact factor: 4.669

4.  Use of Benzodiazepines and Z-Drugs in Nursing Home Residents with Dementia: Prevalence and Appropriateness.

Authors:  Dirk O C Rijksen; Sytse U Zuidema; Esther C de Haas
Journal:  J Alzheimers Dis Rep       Date:  2021-12-09

5.  Stakeholders' views on the use of psychotropic medication in older people: a systematic review.

Authors:  Eliza Bednarczyk; Sarah Cook; Ruth Brauer; Sara Garfield
Journal:  Age Ageing       Date:  2022-03-01       Impact factor: 10.668

6.  Medications causing potential cognitive impairment are common in nursing home dementia units - A cross-sectional study.

Authors:  Jenny Hansen Kristensson; Iris Zahirovic; Elisabet Londos; Sara Modig
Journal:  Explor Res Clin Soc Pharm       Date:  2021-08-05

7.  The course of neuropsychiatric symptoms and psychotropic drug use in Dutch nursing home patients with dementia during the first wave of COVID-19: A longitudinal cohort study.

Authors:  Eefje M Sizoo; Josi A Thunnissen; Anouk M van Loon; Claire L Brederveld; Helma Timmer; Simone Hendriks; Martin Smalbrugge
Journal:  Int J Geriatr Psychiatry       Date:  2022-02       Impact factor: 3.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.